Advancements in technology and practice reported for the first time at AAIC 2023 demonstrate the simplicity, transportability and diagnostic value of blood-based biomarkers for Alzheimer's, including the future potential for at-home testing by a patient or a family member.
Thank you—although the new test looks specifically for the chemical tau (which creates tangles that clog neural networks). I’m digging deeper into early-onset, and wonder if the new test would have done any good, since toxic amyloid-beta plaque deposits may be the bigger culprit there… not sure if tau tangles would have been present in measurable amounts in earlier stages. Just a hypothesis—I’m still digging. There may not be an answer out there (yet).
And as I’ve noted elsewhere, researchers seem unduly narrow in their selection of research participants during development, excluding minorities and women, and most likely atypical early-onset cases as well.
Thank you—although the new test looks specifically for the chemical tau (which creates tangles that clog neural networks). I’m digging deeper into early-onset, and wonder if the new test would have done any good, since toxic amyloid-beta plaque deposits may be the bigger culprit there… not sure if tau tangles would have been present in measurable amounts in earlier stages. Just a hypothesis—I’m still digging. There may not be an answer out there (yet).
And as I’ve noted elsewhere, researchers seem unduly narrow in their selection of research participants during development, excluding minorities and women, and most likely atypical early-onset cases as well.